« Back
Home /
Anti-SARS-CoV Matrix (NT) - 0.1 mg

Anti-SARS-CoV Matrix (NT) - 0.1 mg

Item no.	LEIN-S539-0.1mg
Manufacturer	Leinco Technologies
Amount	0.1 mg
Quantity options	0.1 mg 20 ug
Category	Antibodies ELISA Primary Antibodies Immunostaining
Type	Antibody Primary
Applications	ELISA
Specific against	Virus
Host	Rabbit
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Shipping Condition	Room temperature
Available
Manufacturer - Applications	Quality Tested by Leinco ELISA
Manufacturer - Category	Polyclonal Antibodies\|SARS-CoV-2
Manufacturer - Targets	SARS M
Country of Origin	USA
Shipping Temperature	Next Day Ambient
Storage Conditions	This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Product Description	A coronavirus, SARS (Severe Acute Respiratory Syndrome), was first identified 2002-2003. Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. The M protein (Membrane protein, Matrix protein) is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein and the nucleocapsid protein.
Background	A coronavirus, SARS (Severe Acute Respiratory Syndrome), was first identified 2002-2003. Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. The M protein (Membrane protein, Matrix protein) is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein and the nucleocapsid protein.
PubMed	SARS M
Manufacturer - Research Area	COVID-19, Seasonal and Respiratory Infections, Viral
Manufacturer - Specificity	Rabbit Anti-Human Severe Acute Respiratory Syndrome M (SARS M) recognizes Human SARS M. This polyclonal antibody was purified using affinity chromatography.
RRID	AB_2831777
Concentration	0.5 mg/ml
Formulation	This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Immunogen	Anti-SARS-CoV Matrix antibody was raised against a peptide corresponding to 13 amino acids near the amino-terminus of SARS-CoV Matrix protein. The immunogen is located within the first 50 amino acids of SARS-CoV Matrix.
Additional Information	Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords	Polyclonal Antibody, SARS M, Human, Anti-Severe Acute Respiratory Syndrome M (NT) (SARS M), SARS Matrix Antibody, Membrane protein, E1 glycoprotein, M protein, SARS-CoV, COVID-19

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

LEIN-S539-0.1mg-safety-datasheet.pdf